Li MY et al., 2024-01: Lung adenocarcinoma study reporting that ivermectin downregulates PAK1 and induces non-protective autophagy plus apoptosis in LUAD cells, extending the PAK1 mechanism to lung cancer.
Though ivermectin has been shown to be effective against a variety of cancers, however, there is few available data reporting the antitumor effects of ivermectin in LUAD.
n/a (PubMed abstract)
Li MY et al., 2024-01: Lung adenocarcinoma study reporting that ivermectin downregulates PAK1 and induces non-protective autophagy plus apoptosis in LUAD cells, extending the PAK1 mechanism to lung cancer. Study type: cell lines (in vitro; CCK-8, colony formation, flow cytometry, LC3-GFP/RFP). N: n/a. Country: China (Army Medical University, Chongqing). Dose: in vitro concentrations, not stated in the abstract. Funder: National Natural Science Foundation of China 81972190 and Chongqing programmes. COI: not stated in the record. Comparator: untreated cells.
